NAVBO members receive discounts on registration to IVBM 2016
|
|
|
| Look inside the IVBM Virtual Conference Bag |
|
Lymphatic Forum
in Chicago, IL
June 8-10, 2017
Vascular Biology 2017
Monterey, CA
October 15-19
Chicago, IL
August 7-10, 2017
|
Diamond Level
Welcome Reception Host
|
|
Gold Level
Academic Supporter
 |
|
Silver Level
Academic Supporters
|
|
|
|
Bronze Level
Academic Supporters
|
|
|
|
Online Registration for IVBM Closes Tomorrow!
|
19th International Vascular Biology Meeting
Boston - October 30-November 3
Register online by October 28 to save $$
There will be onsite registration available, but there will be a late fee of $50.
|
The Lab of Dr. Daniela Simona Ardelean
|
One Brave Idea 
Congratulations to Dr. Calum MacRae, chief of Cardiovascular Medicine at Brigham and Women's Hospital, who is the recipient of the "One Brave Idea Research Award" to support his visionary approach to understanding and addressing coronary heart disease (CHD) and its devastating consequences. Nancy Brown, CEO of the American Heart Association said, "Dr. MacRae and his newly-formed, world-renowned, multidisciplinary team were selected from
among hundreds of applicants throughout the world to receive this landmark award that will provide support over a five-year period for a research project focused on uncovering the causes of heart disease, including previously unrecognized signals marking the transition from we llness to the earliest, yet still largely invisible stages of disease." The award is sponsored by AHA, Verily Life Sciences and Astra-Zeneca. Read more
|
|
Welcome our new members:
Karina Gasbarrino, McGill University
Alison Kitajewski, UIC
Yoo-wook Kwon, Seoul National University Hospital
Solomon Mensah, Northeastern University
Anahita Mojiri, University of Alberta
Babak Razani, Washington University
Junchul Shin, Temple University
Jinling Yang, Boston University
|
|
Congratulations to our IVBM Travel Award Recipients!
The Japanese Vascular Biology and Medicine Organization
Katsuya Honda, Kyushu University
Hiroyasu Kidoya, Osaka University
Nako Maishi, Hokkaido University
Takuro Miyazaki, Showa University School of Medicine
Fumitaka Muramatsu, Osaka University
Masashi Muramatsu, Kumamoto University
Sachiko Nishimoto, Tokushima University Graduate School
Keisuke Omori, University of Tokyo
Masahide Sakabe, University of Cincinnati
Tomohisa Sakaue, Ehime University
European Vascular Biology Organization
Koval Smith, Imperial College London
Robert Szulcek, VU University Medical Center
Edwards LifeScience Center for Advanced Cardiovascular Technology with The University of California, Irvine
Jurjan Aman, VU University Medical Centre
Linden Green, Indiana University
Chin Yee Ho, Kings College London
Sungwoon Lee, Yonsei University
Nature Communications
Xuan Jiang, University of California, San Francisco
NAVBO
Graduate Students
John-Michael Arpino, Robart's Research Institute, Western University
Stephanie Bonney, University of Colorado Denver - AMC
Brittany Durgin, University of Virginia
Sergio Esteban, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)
Kevin Kruse, University of Illinois at Chicago
Austin McDonald, UCLA-Caltech Medical Scientist Training Program
Amanda Pellowe, Yale University
Matthew Siviski, Maine Medical Center Research Institute
Pascal Yazbeck, University of Illinois Chicago
Postdoctoral Fellows
Miranda Good, University of Virginia
Enis Kostallari, Mayo Clinic
Andrew Kuo, Yale University
Callie Kwartler, University of Texas Health Science Center at Houston
Chin Nien Lee, Boston Children's Hospital
Laura Pisarsky, Fred Hutchinson Cancer Research Center
Dario Riascos-Bernal, Albert Einstein College of Medicine
Masahiro Shin, Univ of Massachusetts Medical School
Merit Award
Amber Stratman, NICHD/NIH
|
|
Recent Publications by NAVBO Members
|
| Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia
Journal of Cell Biology
Morphogenesis of the vascular system is strongly modulated by mechanical forces from blood flow. Hereditary hemorrhagic telangiectasia (HHT) is an inherited autosomal-dominant disease in which arteriovenous malformations and telangiectasias accumulate with age. Most cases are linked to heterozygous mutations in Alk1 or Endoglin, receptors for bone morphogenetic proteins (BMPs) 9 and 10. Read more Interaction between integrin a5 and PDE4D regulates endothelial inflammatory signalling
Nature Cell Biology
Atherosclerosis is primarily a disease of lipid metabolism and inflammation; however, it is also closely associated with endothelial extracellular matrix (ECM) remodelling, with fibronectin accumulating in the laminin-collagen basement membrane. To investigate how fibronectin modulates inflammation in arteries, we replaced the cytoplasmic tail of the fibronectin receptor integrin a5 with that of the collagen/laminin receptor integrin a2. Read more Hydrogen sulfide therapy in diabetes-accelerated atherosclerosis: a whiff of success
Diabetes
Atherosclerotic cardiovascular disease is the major cause of morbidity and mortality in diabetes (1). Atherosclerosis occurs earlier and with greater severity in the population with diabetes, leading to a much higher risk of myocardial infarction, stroke, and limb ischemia and amputation. Read more |
|
Plan to Attend - Exhibitor Showcases at the IVBM
|
Exhibitor Showcases at the IVBM - Boston
Monday, October 31 from 5:15-6:15pm
Protocols for Measuring Endothelial Barrier Function with ECIS
(from TEER across transwell filters to large scale screens on 96 well plates)
Presentation by Dr. Christian Renken, Applied BioPhysics
Wednesday, November 2 from 4:00-5:00pm
Cellular Heterogeneity in Cardiovascular Disease: Exploring Mechanisms through Single Cell Analysis
Presentation by Julius L. Decano, Brigham and Women's Hospital, Harvard Medical School
Monday, October 31 from 4:00-5:00pm
Targeted proteomics performed on the Q Exactive permits to study the metabolism of circulating apolipoproteins
Sasha A. Singh, Director of Proteomics Center for Interdisciplinary Cardiovascular Sciences Brigham and Women's Hospital, Boston, MA
Translational Proteomics Workflows for Extending the Profiling Range of Plasma/Serum
Scott Peterman and David Sarracino Thermo Fisher Scientific BRIMS, Cambridge, MA
Tuesday, November 1 from 4:00-5:00pm
Unlocking Translational Biomarkers in Vascular Biology with Ultra High Frequency Ultrasound
Presentation by Dr. Julius Decano, Brigham and Women's Hospital
|
Is Faith in Our Research Antibodies Well-placed?
As reported on
NPR
, a
recent meeting
of the
Global Biological Standards Institute (GBSI)
in conjunction with The Antibody Societyexamined industry standards and practices intended to assure the reliability of antibodies used in basic and clinical research.
Several
high-profile examples
of the collapse of promising diagnostic or therapeutic applications of antibodies have brought the issue into the foreground of discussions about reproducibility of research findings. While the GBSI conference focused on the production side of the equation, we scientists at the bench are wise to remember that the burden of validation ultimately lies upon us, and that our attention to potential cross-reactivity, batch-to-batch variability, and altered analyte integrity can spare us disappointment...or worse.
Facebook Founder's Philanthropic Foray
Mark Zuckerberg cannot be accused of setting modest goals. Zuckerberg and his wife, Dr. Priscilla Chan, have posed the question, "Can we
cure, prevent or manage all disease by the end of this century?" and
pledged $3 billion to answer it
. Writing in The Guardian, commentator
Celine Gounder notes
that, although the gift is large and the goal worthy, the amount is but a fraction of that spent via the NIH budget annually toward the same end. Moreover, systemic obstacles exist in the form of a decentralized scientific community conditioned to be risk-averse by the highly competitive nature of the quest for continued funding. The Chan Zuckerberg Initiative seeks to create new forms of cross-institutional collaboration and apply cutting-edge informatics technology to break down cultural barriers and reveal new horizons.
Early Career Award Opportunity
The American Physiological Society invites applications for the
Arthur C. Guyton Award for Excellence in Integrative Physiology
. This ~$30,000 award is intended to support an APS member who is an independent investigator holding an academic rank no higher than Assistant Professor and is pursuing research that utilizes quantitative and integrative approaches and feedback control system theory for the study of physiological functions. Deadline to
apply
is November 13, 2016. Recent awardees have included investigators in vascular biology.
|
|
Job Postings
|
|
Job Title
|
Company
|
Location
|
|
|
Stanford University
|
Palo Alto, CA
|
Acute Care Nurse Practitioner
|
University of Virginia Health System
|
Charlottesville, VA
|
|
|
Collaborating Societies at the IVBM
|
|
Download the IVBM Mobile App
|
Stay up to date on the meeting - download the app for your iOS or Android device.
From the app stores, search NAVBO Events or scan the appropriate QR code:
Please note - more information will continue to be added
|
|
|
